Clinical Trials Logo

Clinical Trial Summary

It is important to bring the blood glucose levels of those with type 2 diabetes mellitus (T2DM) back to normal levels as this can stop the condition from worsening and prevent other conditions that are related to T2DM from developing. One way to maintain healthy blood glucose level is the use of the glycaemic index (GI), which ranks food according to how the body responds to its carbohydrate content. Low GI foods corresponds to low increase in blood glucose levels. Calamansi is a citrus that is believed not to induce an increase in blood glucose levels. Since beverages from calamansi are available and diabetes is a health concern in the community, it is important to investigate the effect of consuming this drink. Finger prick blood were tested in order to obtain the blood glucose levels for calculating the GI for the calamansi drink.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04462016
Study type Interventional
Source University Malaysia Sarawak
Contact
Status Completed
Phase N/A
Start date February 2, 2018
Completion date August 8, 2018

See also
  Status Clinical Trial Phase
Completed NCT05291806 - Second Meal Effects of a Wholegrain Cereal Product on Blood Glucose Response N/A
Completed NCT04197726 - Glycaemic Response to High REsistant STarch Bread N/A
Completed NCT02075333 - The Effect of Ingesting or Rinsing Sucrose and Sucralose on Self-control, Cognitive Performance, and Blood Glucose N/A